» Articles » PMID: 38249081

Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review

Overview
Journal Med Sci (Basel)
Specialty General Medicine
Date 2024 Jan 22
PMID 38249081
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma, a paediatric malignancy with high rates of cancer-related morbidity and mortality, is of significant interest to the field of paediatric cancers. High-risk NB tumours are usually metastatic and result in survival rates of less than 50%. Machine learning approaches have been applied to various neuroblastoma patient data to retrieve relevant clinical and biological information and develop predictive models. Given this background, this study will catalogue and summarise the literature that has used machine learning and statistical methods to analyse data such as multi-omics, histological sections, and medical images to make clinical predictions. Furthermore, the question will be turned on its head, and the use of machine learning to accurately stratify NB patients by risk groups and to predict outcomes, including survival and treatment response, will be summarised. Overall, this study aims to catalogue and summarise the important work conducted to date on the subject of expression-based predictor models and machine learning in neuroblastoma for risk stratification and patient outcomes including survival, and treatment response which may assist and direct future diagnostic and therapeutic efforts.

Citing Articles

Integrated multi-omics characterization of neuroblastoma with bone or bone marrow metastasis.

Huang K, Yang L, Ma Y, Cao L, Li S, Zhao Z Genes Dis. 2025; 12(3):101511.

PMID: 40070366 PMC: 11894310. DOI: 10.1016/j.gendis.2024.101511.


Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohort.

Lozano-Montoya J, Jimenez-Pastor A, Fuster-Matanzo A, Weiss G, Cerda-Alberich L, Veiga-Canuto D Front Oncol. 2025; 15:1528836.

PMID: 40061893 PMC: 11886962. DOI: 10.3389/fonc.2025.1528836.

References
1.
Delen D, Walker G, Kadam A . Predicting breast cancer survivability: a comparison of three data mining methods. Artif Intell Med. 2005; 34(2):113-27. DOI: 10.1016/j.artmed.2004.07.002. View

2.
Brodeur G, Maris J, Yamashiro D, Hogarty M, White P . Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997; 19(2):93-101. DOI: 10.1097/00043426-199703000-00001. View

3.
Florkow M, Guerreiro F, Zijlstra F, Seravalli E, Janssens G, Maduro J . Deep learning-enabled MRI-only photon and proton therapy treatment planning for paediatric abdominal tumours. Radiother Oncol. 2020; 153:220-227. DOI: 10.1016/j.radonc.2020.09.056. View

4.
Liu Y, Jia Y, Hou C, Li N, Zhang N, Yan X . Pathological prognosis classification of patients with neuroblastoma using computational pathology analysis. Comput Biol Med. 2022; 149:105980. DOI: 10.1016/j.compbiomed.2022.105980. View

5.
Bjorklund M . Be careful with your principal components. Evolution. 2019; 73(10):2151-2158. DOI: 10.1111/evo.13835. View